2 unchanged sentences
Exhibit Description
−Removed: Executive Employment Agreement by and between Kirk V.
−Removed: Shephard, M.D.
−Removed: and PDS Biotechnology Corporation, effective as of January 22, 2024 (incorporated by reference to Exhibit 10.27 to the Registrant’s
−Removed: Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 28, 2024).
−Removed: PDS Biotechnology Corporation 2019 Inducement Plan, as amended (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on January 22, 2024, and incorporated by reference herein).
+Added: Amendment to the Eighth Amended and Restated Certificate of Incorporation (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on June 24, 2024, and
+Added: incorporated by reference herein).
Executive Employment Agreement by and between Stephan F.
−Removed: Toutain and PDS Biotechnology Corporation, effective as of May 1, 2024.
+Added: Toutain and PDS Biotechnology Corporation, effective as of May 1, 2024 (filed as Exhibit 10.3 to the Registrant’s
+Added: Quarterly Report on Form 10-Q filed on May 15, 2024, and incorporated by reference herein) .
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
PDS Biotechnology Corporation
+Added: August 13, 2024
/s/ Frank Bedu-Addo
2 unchanged sentences
(Principal Executive Officer)
+Added: August 13, 2024
/s/ Lars Boesgaard
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.